Plandai Biotechnology (Plandai Biotechnology) EPS (Basic) : $-0.00 (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology EPS (Basic)?

Plandai Biotechnology's basic earnings per share (Basic EPS) for the six months ended in Jun. 2023 was $-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00.

Plandai Biotechnology's EPS (Diluted) for the six months ended in Jun. 2023 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00.

Plandai Biotechnology's EPS without NRI for the six months ended in Jun. 2023 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Plandai Biotechnology EPS (Basic) Historical Data

The historical data trend for Plandai Biotechnology's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology EPS (Basic) Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

EPS (Basic)

Get a 7-Day Free Trial

-0.14

-0.07

-0.03

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EPS (Basic)	Get a 7-Day Free Trial											-0.14	-0.07	-0.03	-	-

Plandai Biotechnology EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Plandai Biotechnology's Basic EPS for the fiscal year that ended in Jun. 2023 is calculated as

Basic EPS (A: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-19.801	-	0)	/	7547.551
	=	-0.00

Plandai Biotechnology's Basic EPS for the quarter that ended in Jun. 2023 is calculated as

Basic EPS (Q: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-19.801	-	0)	/	7547.551
	=	-0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00

Plandai Biotechnology (OTCPK:PLPL) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Plandai Biotechnology EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866